Skip to main content

Advertisement

Log in

Tobacco Use and Health-Related Quality of Life Among Individuals with Depression Who Are Receiving Treatment for HIV in Cape Town, South Africa

  • Full length manuscript
  • Published:
International Journal of Behavioral Medicine Aims and scope Submit manuscript

A Correction to this article was published on 01 April 2021

This article has been updated

Abstract

Background

Tobacco use is the leading cause of preventable death worldwide, and prevalence rates are high among people living with HIV (PLWH), particularly in men. Depression is also common among PLWH, especially among smokers, who may use tobacco to manage mood. Although HIV and depression have been linked to functional impairment and poor health-related quality of life (HRQOL), little research has examined the degree to which smoking impacts these relationships in low- and middle-income countries with high HIV burden.

Method

Participants (N = 289) were people living with HIV (PLWH) who were being assessed for inclusion in a study targeting depression as a barrier to HIV medication adherence. Linear regression models measured the effect of gender on tobacco use (assessed by the WHO-ASSIST) and on each of the five HRQOL functional impairment domains (assessed by the SF-21). Separate multivariable regression models examined the relationships between habitual tobacco use, defined as daily, almost daily, or weekly use, and the HRQOL domains.

Results

The prevalence of habitual tobacco use was 23.9% (48.1% among men, 15.5% among women). Habitual tobacco use was associated with decreased cognitive functioning for the whole sample (B = − 8.99, p < 0.05) and with lower levels of pain-related impairment for men (B = 18.1, p < 0.05). Although men reported more tobacco use (B = 8.50, p < 0.001), they reported less pain-related limitations than women (B = 8.70, p < 0.05).

Conclusions

In our sample, men reported higher rates of habitual tobacco use than women. Smoking was associated with cognitive impairment and with less pain-related impairment among men. Future smoking cessation treatments tailored to PLWH who have symptoms of depression may benefit from strategies that consider pain management as a pathway to habitual smoking and recognize that motivations for use may differ by gender.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Change history

References

  1. King D, Grasso C, Dant L, et al. Treatment outcomes associated with quitting cigarettes among sexual minority men living with HIV: antiretroviral adherence, engagement in care, and sustained HIV RNA suppression. AIDS Behav. 2018;22:2868–76.

    Article  PubMed  Google Scholar 

  2. Yin S, Njai R, Barker L, Siegel PZ, Liao Y. Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model. Popul Health Metr [Internet]. 2016 [cited 2019 Oct 9];14. Available from: http://pophealthmetrics.biomedcentral.com/articles/https://doi.org/10.1186/s12963-016-0091-3

  3. AIDSinfo | UNAIDS [Internet]. [cited 2020 Aug 4]. Available from: http://aidsinfo.unaids.org/

  4. National Department of Health. South Africa demographic and health survey 2016. South Africa: Pretoria; 2017.

    Google Scholar 

  5. Reddy P, Zuma K, Shisana O, Kim J, Sewpaul R. Prevalence of tobacco use among adults in South Africa: results from the first South African National Health and Nutrition Examination Survey. S Afr Med J. 2015;105:648–55.

    Article  PubMed  Google Scholar 

  6. Elf JL, Variava E, Chon S, et al. Prevalence and correlates of smoking among people living with HIV in South Africa. Nicotine Tob Res. 2018;20:1124–31.

    Article  PubMed  Google Scholar 

  7. Ziedonis D, Hitsman B, Beckham JC, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008;10:1691–715.

    Article  PubMed  Google Scholar 

  8. Zvolensky MJ, Jardin C, Wall MM, et al. Psychological distress among smokers in the United States: 2008–2014. Nicotine Tob Res. 2018;20:707–13.

    Article  PubMed  Google Scholar 

  9. Nel A, Kagee A. The relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in South Africa. AIDS Care. 2013;25:948–55.

    Article  PubMed  Google Scholar 

  10. Stubbs B, Vancampfort D, Firth J, et al. Association between depression and smoking: a global perspective from 48 low- and middle-income countries. J Psychiatr Res. 2018;103:142–9.

    Article  PubMed  Google Scholar 

  11. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking: a national perspective. JAMA American Medical Association. 1990;264:1541–5.

    Article  CAS  Google Scholar 

  12. Goodwin RD, Wall MM, Garey L, et al. Depression among current, former, and never smokers from 2005 to 2013: the hidden role of disparities in depression in the ongoing tobacco epidemic. Drug Alcohol Depend. 2017;173:191–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Pratt LA, Druss BG, Manderscheid RW, Walker ER. Excess mortality due to depression and anxiety in the United States: results from a nationally representative survey. Gen Hosp Psychiatry. 2016;39:39–45.

    Article  PubMed  Google Scholar 

  14. Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA American Medical Association. 2014;311:183–92.

    Article  CAS  Google Scholar 

  15. Magidson JF, Saal W, Nel A, Remmert JE, Kagee A. Relationship between depressive symptoms, alcohol use, and antiretroviral therapy adherence among HIV-infected, clinic-attending patients in South Africa. J Health Psychol. 2017;22:1426–33.

    Article  PubMed  Google Scholar 

  16. Peltzer K, Rodriguez VJ, Jones D. Prevalence of prenatal depression and associated factors among HIV-positive women in primary care in Mpumalanga province, South Africa. SAHARA J J Soc Asp HIVAIDS Res Alliance. 2016;13:60–7.

    Google Scholar 

  17. Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM. Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study. Neuropsychiatr Dis Treat. 2018;14:1339–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, Hays RD. Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann Intern Med. 2001;134:854–60.

    Article  CAS  PubMed  Google Scholar 

  19. Perez IR, Baño JR, Ruz MAL, et al. Health-related quality of life of patients with HIV: Impact of sociodemographic, clinical and psychosocial factors. Qual Life Res. 2005;14:1301–10.

    Article  Google Scholar 

  20. Engel L, Chen G, Richardson J, Mihalopoulos C. The impact of depression on health-related quality of life and wellbeing: identifying important dimensions and assessing their inclusion in multi-attribute utility instruments. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2018;27:2873–84.

    Article  Google Scholar 

  21. Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med. 2005;20:1142–5.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Turner J, Page-Shafer K, Chin DP, et al. Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDs. 2001;15:615–24.

    Article  CAS  PubMed  Google Scholar 

  23. Kowal J, Overduin LY, Balfour L, Tasca GA, Corace K, Cameron DW. The role of psychological and behavioral variables in quality of life and the experience of bodily pain among persons living with HIV. J Pain Symptom Manage. 2008;36:247–58.

    Article  PubMed  Google Scholar 

  24. Degroote S, Vogelaers D, Vandijck DM. What determines health-related quality of life among people living with HIV: an updated review of the literature. Arch Public Health [Internet]. 2014;72. Available from: https://doi.org/10.1186/2049-3258-72-40

  25. Kariuki W, Manuel JI, Kariuki N, Tuchman E, O’Neal J, Lalanne GA. HIV and smoking: associated risks and prevention strategies. HIVAIDS Auckl NZ. 2015;8:17–36.

    Google Scholar 

  26. Johnson LF. Access to antiretroviral treatment in South Africa, 2004–2011. South Afr J HIV Med. 2012;13:22–7.

    Article  Google Scholar 

  27. Meyer-Rath G, Johnson LF, Pillay Y, et al. Changing the South African national antiretroviral therapy guidelines: the role of cost modelling. PLOS ONE. Public Library of Science; 2017;12:e0186557.

  28. Osler M, Hilderbrand K, Hennessey C, et al. A three-tier framework for monitoring antiretroviral therapy in high HIV burden settings. J Int AIDS Soc. 2014;17:18908.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Goudge J, Gilson L, Russell S, Gumede T, Mills A. Affordability, availability and acceptability barriers to health care for the chronically ill: Longitudinal case studies from South Africa. BMC Health Serv Res. 2009;9:75.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Li V. South Africa’s Return to Primary Care: The Struggles and Strides of the Primary Health Care System. J Glob Health [Internet]. 2014 [cited 2020 Aug 4]; Available from: //www.ghjournal.org/south-africas-return-to-primary-care-the-struggles-and-strides-of-the-primary-health-care-system/

  31. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet Elsevier. 2012;380:2197–223.

    Article  Google Scholar 

  32. Lund C, Kleintjes S, Kakuma R, Flisher AJ, MHaPP Research Programme Consortium. Public sector mental health systems in South Africa: inter-provincial comparisons and policy implications. Soc Psychiatry Psychiatr Epidemiol. 2010;45:393–404.

  33. Seedat S, Williams DR, Herman AA, et al. Mental health service use among South Africans for mood, anxiety and substance use disorders. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 2009;99:346–52.

    Google Scholar 

  34. Kietrys D, Myezwa H, Galantino ML, et al. Functional Limitations and Disability in Persons Living with HIV in South Africa and United States: Similarities and Differences. J Int Assoc Provid AIDS Care JIAPAC. SAGE Publications Inc; 2019;18:2325958219850558.

  35. Tadzimirwa GY, Day C, Esmail A, et al. Challenges for dedicated smoking cessation services in developing countries. S Afr Med J. 2019;109:431.

    Article  CAS  PubMed  Google Scholar 

  36. Riahi F, Rajkumar S, Yach D. Tobacco smoking and nicotine delivery alternatives: patterns of product use and perceptions in 13 countries. F1000Research [Internet]. 2019 [cited 2020 Aug 4];8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518446/

  37. Waldron I, Bratelli G, Carriker L, Sung WC, Vogeli C, Waldman E. Gender differences in tobacco use in Africa, Asia, the Pacific, and Latin America. Soc Sci Med. 1982;1988(27):1269–75.

    Google Scholar 

  38. Africa SS. How do women fare in the South African labour market? | Statistics South Africa [Internet]. [cited 2020 Aug 4]. Available from: http://www.statssa.gov.za/?p=11375

  39. Gabriels CM, Macharia M, Weich L. Psychiatric comorbidity and quality of life in South African alcohol use disorder patients. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2018;27:2975–81.

    Article  Google Scholar 

  40. Joska JA, Andersen LS, Smith-Alvarez R, Magidson J, Lee JS, O’Cleirigh C, Safren SA. Nurse-delivered cognitive behavioral therapy for adherence and depression among people living with HIV (the Ziphamandla Study): protocol for a randomized controlled trial. JMIR Res Protoc. 2020;9(2):e14200.

  41. Sheehan D, Janavs J, Baker R, Sheehan K, Knapp E, Sheehan M. Mini international neuropsychiatric interview–version 7.0. 0 DSM-5. 2014. 2015;

  42. Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.

    Article  PubMed  Google Scholar 

  44. Brislin RW. Back-translation for cross-cultural research. J Cross-Cult Psychol. 1970;1:185–216.

    Article  Google Scholar 

  45. National Department of Health. The 2012 national antenatal sentinel HIV & herpes simplex type-2 prevalence survey in South Africa. Pretoria, South Africa: National Department of Health; 2014.

    Google Scholar 

  46. Stinson K, Goemaere E, Coetzee D, et al. Cohort profile: the Khayelitsha antiretroviral programme, Cape Town. South Africa Int J Epidemiol. 2017;46:e21–e21.

    PubMed  Google Scholar 

  47. Coetzee D, Hilderbrand K, Boulle A, Draper B, Abdullah F, Goemaere E. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull World Health Organ. 2005;83:489–94.

    PubMed  PubMed Central  Google Scholar 

  48. WHO Assist Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97:1183–94.

    Article  Google Scholar 

  49. Batini C, Ahmed T, Ameer S, Kolonzo G, Ozoh U, Smit R van Z. Smoking cessation on the African continent: challenges and opportunities. Afr J Thorac Crit Care Med. 2019;25:46–8.

  50. O’Cleirigh C, Valentine SE, Pinkston M, et al. The unique challenges facing HIV-positive patients who smoke cigarettes: HIV viremia, art adherence, engagement in HIV care, and concurrent substance use. AIDS Behav. 2015;19:178–85.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Wu AW, Huang I-C, Gifford AL, Spritzer KL, Bozzette SA, Hays RD. Creating a crosswalk to estimate AIDS Clinical Trials Group quality of life scores in a nationally representative sample of persons in care for HIV in the United States. HIV Clin Trials. 2005;6:147–57.

    Article  PubMed  Google Scholar 

  52. Safren SA, Hendriksen ES, Smeaton L, et al. Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world. AIDS Behav. 2012;16:266–77.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Damond F, Roquebert B, Bénard A, et al. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Assays. J Clin Microbiol. 2007;45:3436–8.

  54. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.

    Article  Google Scholar 

  55. Pretorius TB. Cross-Cultural Application of the Center for Epidemiological Studies Depression Scale: A Study of Black South African Students: Psychol Rep [Internet]. SAGE PublicationsSage CA: Los Angeles, CA; 2016 [cited 2020 Aug 5]; Available from: https://journals.sagepub.com/doi/https://doi.org/10.2466/pr0.1991.69.3f.1179

  56. Myer L, Smit J, Roux LL, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDs. 2008;22:147–58.

    Article  PubMed  Google Scholar 

  57. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.

    Book  Google Scholar 

  58. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption–II. Addict Abingdon Engl. 1993;88:791–804.

    Article  CAS  Google Scholar 

  59. Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995;56:423–32.

    Article  CAS  PubMed  Google Scholar 

  60. Chinyadza E, Moyo IM, Katsumbe TM, et al. Alcohol problems among patients attending five primary health care clinics in Harare city. Cent Afr J Med. 1993;39:26–32.

    CAS  PubMed  Google Scholar 

  61. Corp IBM. IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp; 2017.

    Google Scholar 

  62. Waweru P, Anderson R, Steel H, Venter WDF, Murdoch D, Feldman C. The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV positive patients in Johannesburg. South Africa S Afr Med J. 2013;103:858–60.

    Article  PubMed  Google Scholar 

  63. Mathew AR, Hogarth L, Leventhal AM, Cook JW, Hitsman B. Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model. Addict Abingdon Engl. 2017;112:401–12.

    Article  Google Scholar 

  64. Kagee A, Martin L. Symptoms of depression and anxiety among a sample of South African patients living with HIV. AIDS Care. 2010;22:159–65.

    Article  PubMed  Google Scholar 

  65. Gehricke J-G, Loughlin SE, Whalen CK, et al. Smoking to self-medicate attentional and emotional dysfunctions. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2007;9(Suppl 4):S523-536.

    Article  Google Scholar 

  66. Malpass D, Higgs S. Acute psychomotor, subjective and physiological responses to smoking in depressed outpatient smokers and matched controls. Psychopharmacology. 2007;190:363–72.

    Article  CAS  PubMed  Google Scholar 

  67. Monnig MA, Kahler CW, Lee H, et al. Effects of smoking and alcohol use on neurocognitive functioning in heavy drinking, HIV-positive men who have sex with men. AIDS Care. 2016;28:300–5.

    Article  PubMed  Google Scholar 

  68. Harrison JD, Dochney JA, Blazekovic S, et al. The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV. J Neurovirol. 2017;23:550–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. McDermott LM, Ebmeier KP. A meta-analysis of depression severity and cognitive function. J Affect Disord. 2009;119:1–8.

    Article  PubMed  Google Scholar 

  70. Labbe AK, Wilner JG, Kosiba JD. Demonstration of an integrated treatment for smoking cessation and anxiety symptoms in people with HIV: A clinical case study. Cogn Behav Pract. 2017;24:200–14.

    Article  Google Scholar 

  71. O’Cleirigh C, Zvolensky MJ, Smits JA. Integrated treatment for smoking cessation, anxiety, and depressed mood in people living with HIV: a randomized controlled trial. JAIDS J Acquir Immune Defic Syndr. 2018;79:261–8.

    Article  PubMed  Google Scholar 

  72. Ditre JW, Brandon TH, Zale EL, Meagher MM. Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychol Bull. 2011;137:1065–93.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Zvolensky MJ, McMillan K, Gonzalez A, Asmundson GJG. Chronic pain and cigarette smoking and nicotine dependence among a representative sample of adults. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2009;11:1407–14.

    Article  CAS  Google Scholar 

  74. Aigner CJ, Gritz ER, Tamí-Maury I, Baum GP, Arduino RC, Vidrine DJ. The role of pain in quitting among human immunodeficiency virus (HIV)-positive smokers enrolled in a smoking cessation trial. Subst Abuse. 2017;38:249–52.

    Article  Google Scholar 

  75. McKetchnie SM, Beaugard C, Taylor SW, O’Cleirigh C. Perspectives on pain, engagement in HIV care, and behavioral interventions for chronic pain among older sexual minority men living with HIV and chronic pain: a qualitative analysis. Pain Med [Internet]. [cited 2020 Nov 24]; Available from: https://academic.oup.com/painmedicine/advance-article/doi/https://doi.org/10.1093/pm/pnaa351/5961457

  76. Aouizerat BE, Miaskowski CA, Gay C, et al. Risk factors and symptoms associated with pain in HIV-infected adults. J Assoc Nurses AIDS Care JANAC. 2010;21:125–33.

    Article  PubMed  Google Scholar 

  77. Ditre JW, Brandon TH. Pain as a motivator of smoking: effects of pain induction on smoking urge and behavior. J Abnorm Psychol. 2008;117:467–72.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. BJA Br J Anaesth. 2013;111:52–8.

    Article  CAS  PubMed  Google Scholar 

  79. Unrod M, Kassel JD, Robinson M. Effects of smoking, distraction, and gender on pain perception. Behav Med Wash DC. 2004;30:133–9.

    Article  Google Scholar 

  80. Reddy P, James S, Sewpaul R, et al. A decade of tobacco control: the South African case of politics, health policy, health promotion and behaviour change. S Afr Med J. 2013;103:835.

    Article  PubMed  Google Scholar 

  81. O’Cleirigh C, Skeer M, Mayer KH, Safren SA. Functional impairment and health care utilization among HIV-infected men who have sex with men: the relationship with depression and post-traumatic stress. J Behav Med. 2009;32:466–77.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Psaros C, O’Cleirigh C, Bullis JR, Markowitz SM, Safren SA. The influence of psychological variables on health related quality of life among HIV positive individuals with a history of intravenous drug use. J Psychoactive Drugs. 2013;45:304–12.

    Article  PubMed  PubMed Central  Google Scholar 

  83. World Health Organization. WHO report on the global tobacco epidemic, 2019 [Internet]. Available from: https://www.who.int/tobacco/surveillance/policy/country_profile/zaf.pdf?ua=1

  84. Murrison L, Martinson N, Moloney RM, et al. Tobacco smoking and tuberculosis among men living with HIV in Johannesburg, South Africa: a case-control study. PLoS ONE. 2016;11:e0167133.

    Article  CAS  Google Scholar 

  85. Andersen LS, Magidson JF, O’Cleirigh C, et al. A pilot study of a nurse-delivered cognitive behavioral therapy intervention (Ziphamandla) for adherence and depression in HIV in South Africa. J Health Psychol. 2018;23:776–87.

    Article  PubMed  Google Scholar 

  86. Everitt-Penhale B, Kagee A, Magidson JF, et al. ‘I went back to being myself’: acceptability of a culturally adapted task-shifted cognitive-behavioural therapy (CBT) treatment for depression (Ziphamandla) for South African HIV care settings. Psychol Health Med. 2019;24:680–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Amelia M. Stanton was supported by a T32 training grant (5T32MH116140-02). Funding for this project came from the National Institute of Mental Health 5R01MH103770 (Safren, O’Cleirigh). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health, or any of the other funders.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amelia M. Stanton.

Ethics declarations

Conflict of Interest

Steven Safren receives royalties from Oxford University Press for treatment manuals on treating depression in chronic illness.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Welfare of Animals

This article does not contain any studies with animals performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original article has been updated to include the missing reference “Joska JA, Andersen LS, Smith-Alvarez R, Magidson J, Lee JS, O’Cleirigh C, Safren SA. Nurse-delivered cognitive behavioral therapy for adherence and depression among people living with HIV (the Ziphamandla Study): protocol for a randomized controlled trial. JMIR Res Protoc. 2020;9(2):e14200” and the corresponding citation has been included near the sentence “Participants in the present study completed the baseline assessment of a trial to treat clinical depression and ultimately improve ART adherence.”

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stanton, A.M., Lee, J.S., Wirtz, M.R. et al. Tobacco Use and Health-Related Quality of Life Among Individuals with Depression Who Are Receiving Treatment for HIV in Cape Town, South Africa. Int.J. Behav. Med. 28, 417–430 (2021). https://doi.org/10.1007/s12529-020-09951-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12529-020-09951-z

Keywords

Navigation